Literature DB >> 19260443

Antiretroviral therapy in the Malawi police force: access to therapy and treatment outcomes.

Simon D Makombe1, Andreas Jahn, Hannock Tweya, Stuart Chuka, Joseph Kwong-Leung Yu, Bethany Hedt, Ralf Weigel, Amon Nkhata, Erik J Schouten, Kelita Kamoto, Anthony D Harries.   

Abstract

A national survey was carried out in all the 103 public sector and 38 private sector facilities in Malawi providing antiretroviral therapy (ART) to determine uptake of ART and subsequent treatment outcomes in police force personnel. All patients registered for ART and their subsequent treatment outcomes were censored on December 31st 2006. There were 85168 patients started on ART in both public and private sectors, of whom 463 (0.6%) were police force personnel. Of police force personnel starting ART, 17% were in WHO clinical stage 1 or 2 with a CD4-lymphocyte count of < or = 250 cells/microL and 83% were in stage 3 or 4. Treatment outcomes of police force personnel by the end of December 2006 were 302 (65%) alive and on ART at their registration facility, 59 (13%) dead, 30 (7%) lost to follow-up, 1 stopped treatment and 71 (15%) transferred to another facility. Their probability of being alive on ART at 6-, 12- and 18-months was 83.2%, 78.6% and 76.7% respectively. There has been a good access of police force personnel to ART since national scale up commenced with good treatment outcomes, and this should serve as an example for other police forces in the region.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19260443      PMCID: PMC3345663          DOI: 10.4314/mmj.v20i1.10951

Source DB:  PubMed          Journal:  Malawi Med J        ISSN: 1995-7262            Impact factor:   0.875


  12 in total

1.  Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

Authors:  Laurent Ferradini; Arnaud Jeannin; Loretxu Pinoges; Jacques Izopet; Didakus Odhiambo; Limangeni Mankhambo; Gloria Karungi; Elisabeth Szumilin; Serge Balandine; Gaëlle Fedida; M Patrizia Carrieri; Bruno Spire; Nathan Ford; Jean-Michel Tassie; Philippe J Guerin; Chris Brasher
Journal:  Lancet       Date:  2006-04-22       Impact factor: 79.321

2.  Turning the tide on the AIDS pandemic.

Authors:  William J Clinton
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

3.  Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes--the case of Malawi.

Authors:  E Libamba; S Makombe; A D Harries; R Chimzizi; F M Salaniponi; E J Schouten; R Mpazanje
Journal:  Int J Tuberc Lung Dis       Date:  2005-10       Impact factor: 2.373

4.  Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya.

Authors:  Kara Wools-Kaloustian; Silvester Kimaiyo; Lameck Diero; Abraham Siika; John Sidle; Constantin T Yiannoutsos; Beverly Musick; Robert Einterz; Kenneth H Fife; William M Tierney
Journal:  AIDS       Date:  2006-01-02       Impact factor: 4.177

5.  Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi.

Authors:  Edwin Libamba; Simon Makombe; Eustice Mhango; Olga de Ascurra Teck; Eddie Limbambala; Erik J Schouten; Anthony D Harries
Journal:  Bull World Health Organ       Date:  2006-04-13       Impact factor: 9.408

6.  Scaling up antiretroviral treatment in resource-poor settings.

Authors:  Anthony D Harries; Erik J Schouten; Edwin Libamba
Journal:  Lancet       Date:  2006-06-03       Impact factor: 79.321

7.  A community-based study of the incidence of trimethoprim-sulfamethoxazole-preventable infections in Malawian adults living with HIV.

Authors:  Joep J G van Oosterhout; Miriam K Laufer; Stephen M Graham; Feston Thumba; M Arantza Perez; Nelson Chimbiya; Lorna Wilson; Maganizo Chagomerana; Malcolm E Molyneux; Eduard E Zijlstra; Terrie E Taylor; Christopher V Plowe
Journal:  J Acquir Immune Defic Syndr       Date:  2005-08-15       Impact factor: 3.731

8.  Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design.

Authors:  Stephen D Lawn; Landon Myer; Catherine Orrell; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2005-12-02       Impact factor: 4.177

9.  Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana.

Authors:  C William Wester; Soyeon Kim; Hermann Bussmann; Ava Avalos; Ndwapi Ndwapi; Trevor F Peter; Tendani Gaolathe; Andrew Mujugira; Lesego Busang; Chris Vanderwarker; Peter Cardiello; Onalethata Johnson; Ibou Thior; Patson Mazonde; Howard Moffat; Max Essex; Richard Marlink
Journal:  J Acquir Immune Defic Syndr       Date:  2005-11-01       Impact factor: 3.731

10.  Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort.

Authors:  Alexandra Calmy; Lorextu Pinoges; Elisabeth Szumilin; Rony Zachariah; Nathan Ford; Laurent Ferradini
Journal:  AIDS       Date:  2006-05-12       Impact factor: 4.177

View more
  3 in total

1.  Gender differences in retention and survival on antiretroviral therapy of HIV-1 infected adults in Malawi.

Authors:  Katie Taylor-Smith; Hannock Tweya; Anthony Harries; Erik Schoutene; Andreas Jahn
Journal:  Malawi Med J       Date:  2010-06       Impact factor: 0.875

2.  How operational research influenced the scale up of antiretroviral therapy in Malawi.

Authors:  Anthony D Harries; Simon D Makombe; Erik J Schouten; Andreas Jahn; Edwin Libamba; Kelita Kamoto; Frank Chimbwandira
Journal:  Health Care Manag Sci       Date:  2011-11-24

3.  Improving data quality and supervision of antiretroviral therapy sites in Malawi: an application of Lot Quality Assurance Sampling.

Authors:  Bethany L Hedt-Gauthier; Lyson Tenthani; Shira Mitchell; Frank M Chimbwandira; Simon Makombe; Zengani Chirwa; Erik J Schouten; Marcello Pagano; Andreas Jahn
Journal:  BMC Health Serv Res       Date:  2012-07-09       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.